Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: A cohort study.
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Question: Is broad-spectrum antibiotic use associated with poor outcomes in community-onset pneumonia after adjusting for confounders? Methods: We performed a retrospective, observational cohort study of 1995 adults with pneumonia admitted from four US hospital emergency departments. We used multivariable regressions to investigate the effect of broad-spectrum antibiotics on 30-day mortality, length of stay, cost and Clostridioides difficile infection (CDI). To address indication bias, we developed a propensity score using multilevel (individual provider) generalised linear mixed models to perform inverse-probability of treatment weighting (IPTW) to estimate the average treatment effect in the treated. We also manually reviewed a sample of mortality cases for antibiotic-associated adverse events. Results: 39.7% of patients received broad-spectrum antibiotics, but drug-resistant pathogens were recovered in only 3%. Broad-spectrum antibiotics were associated with increased mortality in both the unweighted multivariable model (OR 3.8, 95% CI 2.5–5.9; p<0.001) and IPTW analysis (OR 4.6, 95% CI 2.9–7.5; p<0.001). Broad-spectrum antibiotic use by either analysis was also associated with longer hospital stay, greater cost and increased CDI. Healthcare-associated pneumonia was not associated with mortality independent of broad-spectrum antibiotic use. In manual review we identified antibiotic-associated events in 17.5% of mortality cases. Conclusion: Broad-spectrum antibiotics appear to be associated with increased mortality and other poor outcomes in community-onset pneumonia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among undifferentiated patients with pneumonia or sepsis, broad-spectrum regimens including agents active against MRSA were associated with higher mortality, particularly among patients without MRSA [137, 151, 155, 156].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [156]
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Self-citation(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Austin, P. C., & Stuart, E. A. (2015) · Statistics in Medicine · doi:10.1002/sim.6607 · Cited by 4,495
Generalized Additive Models for Location Scale and Shape (GAMLSS) in R
Stasinopoulos, D. M., & Rigby, R. A. (2007) · Journal of Statistical Software · doi:10.18637/jss.v023.i07 · Cited by 1,560
Emergency Department Visits for Antibiotic‐Associated Adverse Events
Shehab, N., Patel, P. R., Srinivasan, A., & Budnitz, D. S. (2008) · Clinical Infectious Diseases · doi:10.1086/591126 · Cited by 535
Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012
Baggs, J., Fridkin, S. K., Pollack, L. A., Srinivasan, A., & Jernigan, J. A. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5651 · Cited by 268
Chalmers, J. D., Rother, C., Salih, W., & Ewig, S. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit734 · Cited by 251
Luther, M. K., Timbrook, T. T., Caffrey, A. R., Dosa, D., Lodise, T. P., & LaPlante, K. L. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002769 · Cited by 235
Research works printed but not linked: 1
- Mecham ID, 2018, The association of qSOFA, SOFA and SIRSA with mortality in emergency department pneumonia patients, J Respir Infect, 97, e12634
Cited by
Items 101–180 of 180
WATERER, G. W. (2019) · European Respiratory Journal · doi:10.1183/13993003.00870-2019 · Cited by 4
Pickens, C. I. (2025) · CHEST Journal · doi:10.1016/j.chest.2024.08.052 · Cited by 4
Shiroshita, A., Yamamoto, S., Anan, K., Suzuki, H., Takeshita, M., & Kataoka, Y. (2022) · International Journal of COPD · doi:10.2147/copd.s386965 · Cited by 3
“3) Partially dependent (%) 772 (88) 412 (89) 1184 (88) Full Dependent (%) 109 (12) 48 (10) 157 (12) Missing data (%) 17 (1)”
Niforatos, J. D., Hinson, J. S., Rothman, R. E., Cosgrove, S. E., Dzintars, K., & Klein, E. Y. (2025) · Journal of the American College of Emergency Physicians Open · doi:10.1016/j.acepjo.2024.100021 · Cited by 3
“%) patients received alternative MRSA antibiotics in the ED, respectively.”
InfluentialKudoh, R., Yoneoka, D., Hagiwara, A., Shuto, H., Omori, S., Fushimi, K., & Komiya, K. (2025) · Antibiotics · doi:10.3390/antibiotics14080743 · Cited by 3
“…conducted in four emergency departments in the USA including patient data obtained in 1995 showed that the use of antipseudomonal agents in CAP was associated with a significantly higher 30-day mortality rate, increased risk of Clostridioides difficile infection, and prolonged hospitalization [17].”
Zhang, J. Z., Chan, C. H. T., Chang, L. C., Chiu, L. C. S., Ng, P. Y., Dharmangadan, M., Ho, E., Ling, S. K.-H., Man, M. Y., Fong, K. M., et al. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf752 · Cited by 3
“Although adequate empirical antibiotics is essential, use of overly broad antibiotics has been associated with increased mortality [21, 22].”
Kaushal, A., Goyal, N., Arora, R., Jain, A., Singh, N. P., & Das, S. (2024) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2024.102510 · Cited by 3
Diagnostic Accuracy of Procalcitonin upon Emergency Department Admission during SARS-CoV-2 Pandemic
Malinverni, S., Lazzaroni, S., Nuňez, M., Préseau, T., COTTON, F. J., Martiny, D., Bouazza, F.-Z., Collot, V., Konopnicki, D., Alard, S., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11091141 · Cited by 3
“While a delay in antibiotic treatment of bacterial community-acquired pneumonia (CAP) is associated with increased mortality [6], systematic broad-spectrum antibiotic treatment of suspected bacterial CAP is associated with complications, side effects, and mortality [7].”
BackgroundTjoa, E., Joon, S., Moehario, L. H., Loe, L., & Pangalila, F. J. V. (2022) · Journal of International Medical Research · doi:10.1177/03000605221123678 · Cited by 3
ERS International Congress, Madrid, 2019: highlights from the Respiratory Infections Assembly
Călăraşu, C., Chichirelo-Konstantynovych, K. D., & Frent, S. (2020) · ERJ Open Research · doi:10.1183/23120541.00316-2019 · Cited by 3
Risk stratification for selecting empiric antibiotherapy during and after COVID-19
Zahar, J., & Timsit, J. (2022) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000881 · Cited by 3
Rajamaki, B., Braithwaite, B., Hartikainen, S. A., & Tolppanen, A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240490 · Cited by 2
Evaluation of a Novel Rapid Phenotypic Antimicrobial Susceptibility Testing System
Xue, Y. C., Cerqueira, F. M., Williams‐Bouyer, N., & Ren, P. (2025) · Antibiotics · doi:10.3390/antibiotics14100962 · Cited by 2
Rahme, D., Chmaisse, H. N., & Salameh, P. (2025) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2025.100669 · Cited by 2
“14 – 17 In patients with CAP, infections caused by resistant pathogens are associated with twice the mortality and financial burden compared to those caused by susceptible strains.”
Barchet, A. C., Fleming, J. N., Rydz, A. C., Steuber, T. D., & Thayer, B. (2025) · Hospital Pharmacy · doi:10.1177/00185787251393063 · Cited by 2
Aoto, K., Inose, R., & Muraki, Y. (2026) · PLoS ONE · doi:10.1371/journal.pone.0346452 · Cited by 2
“Consequently, the consistent benefits of broad-spectrum empiric therapy on patient outcomes have been questioned, and the overuse of broad-spectrum antibiotics in empiric therapy has been recognized as an issue that needs to be addressed [11,16–18].”
Naseem, A., Hashmi, F. K., Saleem, Z., Javaid, H., Afzal, Z., Shakeel, N., Tariq, B., Akbar, N., Asghar, A., Zahid, R., et al. (2026) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-026-00589-w · Cited by 2
“In pediatric population, the misuse of broad-spectrum antibiotics have been widely reported and is associated with increased risk of multidrug-resistant infections, treatment failures and pro - longed hospitalization [18, 19].”
Patterns, price and predictors of successful empiric antibiotic therapy in a real‐world setting
Akinosoglou, K., Koutsouri, C., Delastic, A., Κολόσακα, Μ., Davoulos, C., Niarou, V., Kosmopoulou, F., Ziazias, D., Theodoraki, S., & Gogos, C. A. (2021) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13372 · Cited by 2
Cincilevičiūtė, G., Averjanovaitė, V., Mereškevičienė, R., Pliatkienė, G., Zablockis, R., & Danila, E. (2021) · Advances in respiratory medicine · doi:10.5603/arm.a2021.0070 · Cited by 2
“In their cohort study, Webb et al. (2019) have shown that 39.7% of patients received broad-spectrum antibiotics, but drug-resistant pathogens have been recovered in only 3%.”
BackgroundInfluentialERS International Congress 2020: highlights from the Respiratory Infections assembly
Frent, S., Călăraşu, C., Suska, K., Gashynova, K., & Keir, H. R. (2021) · ERJ Open Research · doi:10.1183/23120541.00091-2021 · Cited by 2
Wibisono, A., Harb, G., Crotty, M. P., Rahmanzadeh, K., Alexander, J., Hunter, L., & Dominguez, E. P. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac659 · Cited by 2
“Frequently, patients are treated with broad-spectrum antibiotics although there appears to be a substantial difference between perceived risk and actual detection of resistant pathogens [12, 13].”
BackgroundWATERER, G. W., & Gleeson, L. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00199-2 · Cited by 2
Estudo multicntrico de avaliação da prescrição de antimicrobianos em hospitais brasileiros
Porto, A. P. M. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-22092022-160249 · Cited by 2
Bhattacharyya, M., Saha, A., & Todi, S. K. (2024) · Journal of Intensive Care Medicine · doi:10.1177/08850666241234625 · Cited by 1
“12,13 In our study, the use of combination antibiotics in both HS and HU groups might have resulted in unnecessary antibiotic usage, and the expected bene fi t from such therapy was not evident in our results.”
Ten Clinical Pearls in Microbiology: How Effective Collaboration Optimizes Patient Care
Lam, J. C., & Bourassa‐Blanchette, S. (2024) · The American Journal of Medicine · doi:10.1016/j.amjmed.2024.05.013 · Cited by 1
Jing, C., Ding, Y., Zhou, J., Zhang, Q., Wang, M., Ou, Q., Liu, J., Xv, T., Feng, C., Yuan, D., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110218 · Cited by 1
Guénézan, J., Deroche, L., Marjanovic, N. S., Piton, M., Drugeon, B., Bigaud, B., Billaud, M., Lévêque, N., & Mimoz, O. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05370-8 · Cited by 1
Yang, L., Lu, Y., Chen, Y., Deng, F., Li, M., & zhang, C. (2026) · Journal of Chromatography B · doi:10.1016/j.jchromb.2026.125131 · Cited by 1
Klompas, M., & Rhee, C. (2026) · Clinical Infectious Diseases · doi:10.1093/cid/ciag330 · Cited by 1
Lee, Y., Kim, J., Han, M., Lee, J. A., Kim, J. H., Ahn, J. Y., Jeong, S. J., Ku, N. S., Choi, J. Y., Yeom, J., et al. (2026) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2026.107915 · Cited by 1
Cillóniz, C., Pericàs, J. M., & Restrepo, M. I. (2026) · CHEST Journal · doi:10.1016/j.chest.2026.06.050 · Cited by 1
Precision antimicrobials: the next paradigm shift after broad-spectrum therapy
Shanmugam, N. R. S., Marimuthu, S. K., Kumaran, M., & Tharmalingam, N. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1881800 · Cited by 1
“In cases with negative bacteriological results, alternative diagnoses may have been missed (Webb et al., 2019).”
InfluentialXue, Y. C., Williams‐Bouyer, N., & Ren, P. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1890096 · Cited by 1
Heo, I. R., & Kim, S. (2026) · PLoS ONE · doi:10.1371/journal.pone.0358986 · Cited by 1
“Delayed pathogen identification contributes to prolonged empirical broad-spectrum antibiotic use, which is associated with adverse drug events, antimicrobial resistance, prolonged hospitalization, and mortality [9].”
Eberhard, A., & Mellhammar, L. (2024) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2023.2299676 · Cited by 1
“Unnecessarily broad antimicrobial therapy is also associated with higher mortality, probably due to collateral damage [24,25].”
BackgroundRisk of Multidrug-Resistant Pathogens in Severe Community-Acquired Pneumonia
Campaña-Duel, E., Camprubí–Rimblas, M., Areny‐Balagueró, A., Quero, S., Artigas, A., & Ceccato, A. (2024) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0043-1778138 · Cited by 1
Epps, J. V., Lepak, A. J., Schulz, L. T., & Fish, J. T. (2024) · Journal of Intensive Care Medicine · doi:10.1177/08850666241254736 · Cited by 1
Clauss, S., Bourlet, S., Jaffal, K., Duran, C., D’Anglejan, E., Perronne, V., Bouchand, F., Noussair, L., Dahmane, L., & Dinh, A. (2024) · Infectious Diseases Now · doi:10.1016/j.idnow.2024.104933 · Cited by 1
Albuquerque, A. A. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/9agj-5w72
Iwami, K., Matsuo, T., Hayashi, K., & Mori, N. (2021) · Research Square · doi:10.21203/rs.3.rs-408340/v1
Chang, C.-M., Hsieh, M., Yang, C., Meng, Y.-H., Li, T.-Y., & Chen, P. (2022) · Research Square · doi:10.21203/rs.3.rs-1367638/v1
Can Electronic Decision Support Tools Really Reduce Mortality from Community-acquired Pneumonia?
WATERER, G. W., & Donaldson, G. C. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202202-0358ed
“The ePNa builds on previous work from the investigators (6) and aims to provide standardized guidance around the diagnosis, risk stratification, microbiology studies, site of care, and antibiotic therapy in the setting of CAP.”
BackgroundInfluentialWang, H.-C., Tsai, M.-H., Chu, S., Liao, C.-C., Lai, M., Chiang, M., Fu, R.-H., Hsu, J., & Huang, H. (2021) · Research Square · doi:10.21203/rs.3.rs-469707/v1
Shiroshita, A., Miyakoshi, C., Tsutsumi, S., Shiba, H., Shirakawa, C., Sato, K., Matsushita, S., Kimura, Y., Tomii, K., Ohgiya, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-714241/v1
Antibiotic Prescriptions in Pediatric Patients Hospitalized with Pneumonia at a University Hospital
Leite, R. R., do Amaral, F. L. E., Bié, S. M. G., da Silva, M. F. B., Oliveira, S. M. D. A., da Silva, J. D. O., & Ferreira, S. B. (2022) · International Electronic Conference on Antibiotics (ECA) · doi:10.3390/eca2022-12690
“and the use of more potent antibiotics [15].”
BackgroundAdvances in molecular diagnostic tests for community-acquired pneumonia
Cillóniz, C., Poliakova, Y., & Hurtado, J. C. (2023) · Minerva Respiratory Medicine · doi:10.23736/s2784-8477.22.02044-7
Antibacterial Therapy in Adults with COVID-19
Allard, S. D., & Laethem, J. V. (2023) · MDPI eBooks · doi:10.3390/books978-3-0365-6812-6
Bono, K. R., Caceda, J. A., Zhai, M., Horng, H., Goldstein, C., Sifri, Z. C., Jobbágy, Z., & Glass, N. E. (2023) · Journal of Surgical Research · doi:10.1016/j.jss.2023.10.026
The Role of Targeted Next-Generation Sequencing in Pathogen Detection
罗, 宁. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.141101
Shiroshita, A., Tochitani, K., Maki, Y., Terayama, T., & Kataoka, Y. (2024) · Antibiotics · doi:10.3390/antibiotics13050383
Hosni, A. M., Moawad, A., Abdelateef, H., Rahman, M. A. E., El-Tayeb, A., & Khalil, N. (2024) · Bulletin of Pharmaceutical Sciences Assiut · doi:10.21608/bfsa.2024.269133.2028
Tate, T., Viehman, J. A., & Shields, R. K. (2024) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2024.430
“Given that prolonged use of broad spectrum antibiotics increases the risk of antibiotic resistance, Clostridioides difficile infection, and central line complications, 11,12 reducing time to targeted therapy by nearly 48 hours is likely associated with improved patient safety and lower costs.”
BackgroundZhang, R., Xu, H., Zhang, X., Xiong, H., Tang, F., Lv, L., Mu, X., Tian, W., Cheng, Y., Lu, J., et al. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s483256
Shimada, Y., Ohbe, H., Kutsuna, S., Kosaka, S., Matsui, H., & Yasunaga, H. (2024) · Internal Medicine · doi:10.2169/internalmedicine.4426-24
“Recent studies have highlighted the risk of unnecessary broad-spectrum antibiotics in community-acquired settings with low antimicrobial resistance (29, 30).”
Pneumonia in the elderly from the perspective of adult pneumonia practice guideline 2024 in Japan
直樹, 岩., & 迎, 寛. (2025) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.62.1
Abe, T., Iriyama, H., Imaeda, T., Oami, T., Aizimu, T., Takahashi, N., Yamao, Y., Nakagawa, S., Ogura, H., Umemura, Y., et al. (2025) · Respiratory Medicine · doi:10.1016/j.rmed.2025.108366
Deshpande, A., Walker, R. E., Schulte, R. J., Pallotta, A. M., Tereshchenko, L. G., Hu, B., Kadri, S. S., Klompas, M., & Rothberg, M. B. (2023) · Figshare · doi:10.6084/m9.figshare.24152475
Prodrug Activation in Staphylococci and the Implications for Antimicrobial Development
Miller, J. (2021) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/r5w0-xy51
Wang, H.-C., Tsai, M.-H., Chu, S.-M., Liao, C.-C., Lai, M.-Y., Huang, H.-R., Chiang, M.-C., Fu, R.-H., & Hsu, J.-F. (2021) · Figshare · doi:10.6084/m9.figshare.16639579
Sellés, N. A., & de Medicina, U. A. D. B. D. (2019) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona)
Bhatia, M., Davanzo, K., Kim, P. C., Inampudi, J. V., Shapoo, M., Scipione, M. R., Dhar, S., & Monday, L. (2025) · LabMed · doi:10.3390/labmed3010001
“This could be related to increased incidence of multidrug-resistant infections, Clostridium difficile colitis and Enterococcus spp. Bacteremia [27–30].”
Joy, S., Philip, N. S., & John, N. S. (2026) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2026.101066
Yue, J., Guo, Y., Yang, S., Xia, Y., Gong, L., Liu, J., Jiang, Y., Zhang, M., Xie, N., & Liao, T. (2026) · BMC Microbiology · doi:10.1186/s12866-026-04784-4
“…workflows, especially for multidrug-resistant (MDR) infections, are time-consuming, often taking several days, which delays targeted treatment and contributes to the overuse of broad-spectrum antibiotics, increasing the risk of antimicrobial resistance (AMR), adverse effects, and mortality [8–11].”
RNA Sequencing of Sepsis Patients Informs Tests to Quickly Diagnose Pathogens and Resistance
Monaghan, S. F., Shin, J., Armstead, B. E., Ayala, A., Cohen, M., Fairbrother, W. G., Levy, M. M., Lillard, K. K., Raggi, E., Nau, G. J., et al. (2026) · Shock · doi:10.1097/shk.0000000000002756
“While broad-spectrum antibiotics may provide appropriate empiric coverage, they are independently associated with an adjusted increased risk of mortality (13).”
Kawasuji, H., Maruyama, T., Aoki, N., Koshiyama, Y., Nagaoka, K., Katsurada, M., Sano, M., Shindo, Y., Iwanaga, N., Horita, N., et al. (2026) · Respiratory Investigation · doi:10.1016/j.resinv.2026.101410
Targeted metagenomics for diagnosis of bacterial infection.
Flurin, L. (2022) · theses.fr (ABES) · doi:10.70675/c2436b4ez59abz42a2z9285z9cdba177bc94
Axillary Lymph Node Calcifications due to Tattoo Pigment: A Radiologic-Pathologic Correlation
López-Herrero, M., Pitarch, M., Giner, M., Lopez-Segura, D., & de Alcântara, R. C. (2026) · European Journal of Breast Health · doi:10.4274/ejbh.galenos.2025.2025-9-11
Budnick, I. M., Park, S., Rolloff, K. P., Brinton, J. T., Reisz, J. A., Stephenson, D., Haeger, S. M., Smith, A., Okamura, K., He, Z., et al. (2026) · Kidney Medicine · doi:10.1016/j.xkme.2026.101449
Laila, A., & Sebastian, J. (2026) · Pharmacy Practice · doi:10.18549/pharmpract.2026.2.3284
“For instance, one study defined broad-spectrum antibiotics for CAP as agents covering MRSA or Pseudomonas, excluding fluoroquinolones due to their recommendation as monotherapy for CAP 10 .”
Pharmacist-Led Antimicrobial Stewardship Using Xpert MRSA/SA BC
Maruyama, K., & Sekiya, K. (2026) · Japanese Journal of Infection Prevention and Control · doi:10.4058/jsei.41.35
Kudoh, R., Yoneoka, D., Hagiwara, A., Shuto, H., Omori, S., Fushimi, K., & Komiya, K. (2026) · Research Square · doi:10.21203/rs.3.rs-10472447/v1
Zhang, Y., Liu, Q., Zhang, F., Bai, Y., Geng, Y., Zhang, J., Wang, S., Liu, Y., Wang, L., Fan, K., et al. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7536108
Iswandi, I., Harsono, S. B., & Hakimah, F. (2026) · MEDFARM Jurnal Farmasi dan Kesehatan
Key Points of the New Pneumonia Clinical Practice Guidelines
直樹, 岩., & Mukae, H. (2025) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.114.2000
Cillóniz, C., McDonald, E. G., Guglielmi, R., & Reyes, L. F. (2026) · CMI Communications · doi:10.1016/j.cmicom.2026.105234
Mu, S., Hu, L., Zhang, Y., Liu, Y., Cui, X., Zou, X., Wang, Y., Lu, B., Zhou, S., Liang, X., et al. (2021) · doi:10.3389/fcimb.2021.684965.s002
Metadata
- Authors
- Webb, B. J., Sorensen, J., Jephson, A., Mecham, I., & Dean, N. C.
- Affiliations
- Intermountain Healthcare (US)
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-04-25
- Volume
- 54
- Issue
- 1
- Pages
- 1900057
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2941945808
- Cited by
- 164
- References
- 40
- Citations by year
- 2026: 17 · 2025: 32 · 2024: 24 · 2023: 28 · 2022: 20 · 2021: 21 · 2020: 18 · 2019: 4
- FWCI
- 11.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Intermountain Research and Medical Foundation
- Topics
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- broad-spectrum antibiotics, community-onset pneumonia, 30-day mortality, Clostridium difficile infection, healthcare-associated pneumonia, length of hospital stay, health care costs, drug-resistant pathogens, emergency department admission, propensity score weighting
- MeSH terms
- Aged, Anti-Bacterial Agents, Clostridium Infections, Female, Humans, Length of Stay, Male, Middle Aged, Pneumonia, Retrospective Studies, Time Factors, Utah, Multivariate Analysis, Linear Models, Databases, Factual, Community-Acquired Infections, Drug Resistance, Bacterial, Propensity Score
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.